Active ingredients:

ATP-LONG 10 mg or 20 mg, Adenine Nucleotide 6.3 mg/12.6 mg.

ATP-LONG is a unique new class medicine containing adenosine-5’- triphosphate (ATP), histidine amino acid, magnesium and potassium. Its original molecule structure demonstrates a pharmacological effect, which none of its chemical components has. ATP-LONG’s effect is anti-ischemial, membrane stabilizing and antiarrhythmic. ATP-LONG normalizes metabolism, improves the myocardial anti-oxidation protection system, and reduces accumulation of hydrolysis products in membranes and the peroxidation of phospholipids. ATP-LONG improves central and peripheral hemodynamics and coronary blood circulation, and increases myocardial contractile ability, the function of the left ventricle and cardiac output, resulting in better physical efficiency. ATP-LONG reduces the frequency of stenocardia, normalizes potassium and magnesium tissue concentrations and reduces uric acid concentrations.

Indications

• indicated for the treatment of cardiac ischemia, unstable stenocardia;
• post-infarction and myocardial cardiosclerosis;
• cardiac insufficiency;
• tachycardia;
• vegetovascular dystonia;
• myocardial dystrophy;
• infectious allergic myocarditis;
• chronic fatigue syndrome.

Dosage and pharmaceutical form:

tablets 10 mg or 20 mg, 10 tablets in blister, 4 blisters in package.